Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $89,961 | 59 | 57.6% |
| Travel and Lodging | $39,530 | 105 | 25.3% |
| Consulting Fee | $10,715 | 15 | 6.9% |
| Honoraria | $8,341 | 8 | 5.3% |
| Food and Beverage | $4,478 | 57 | 2.9% |
| Grant | $1,950 | 2 | 1.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,250 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $81,051 | 138 | $0 (2024) |
| PFIZER INC. | $22,971 | 29 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $20,519 | 28 | $0 (2024) |
| GlaxoSmithKline, LLC. | $17,541 | 24 | $0 (2022) |
| Karyopharm Therapeutics Inc. | $8,999 | 16 | $0 (2022) |
| GENZYME CORPORATION | $2,004 | 3 | $0 (2023) |
| Celgene Corporation | $1,650 | 5 | $0 (2024) |
| Janssen Global Services, LLC | $1,060 | 1 | $0 (2024) |
| Legend Biotech USA Inc. | $263.59 | 3 | $0 (2024) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $109.02 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56,095 | 87 | Janssen Biotech, Inc. ($39,033) |
| 2023 | $61,838 | 101 | Janssen Biotech, Inc. ($31,320) |
| 2022 | $22,786 | 37 | GlaxoSmithKline, LLC. ($11,205) |
| 2021 | $15,506 | 24 | Karyopharm Therapeutics Inc. ($7,999) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: Oncology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | ABECMA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,327.00 | General |
| Category: Oncology | ||||||
| 12/16/2024 | PFIZER INC. | ELREXFIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | PFIZER INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| 12/13/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $804.06 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $139.25 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $88.58 | General |
| Category: Oncology | ||||||
| 12/09/2024 | PFIZER INC. | ELREXFIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Oncology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ABECMA (Biological) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: Oncology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | ABECMA (Biological) | Travel and Lodging | Cash or cash equivalent | $781.80 | General |
| Category: Oncology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | ABECMA (Biological) | Travel and Lodging | Cash or cash equivalent | $203.82 | General |
| Category: Oncology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | ABECMA (Biological) | Travel and Lodging | Cash or cash equivalent | $45.41 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Travel and Lodging | In-kind items and services | $202.30 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Travel and Lodging | In-kind items and services | $349.25 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,175.00 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $121.65 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $33.97 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $11.00 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Travel and Lodging | In-kind items and services | $353.45 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 177 | 299 | $98,750 | $25,584 |
| 2022 | 3 | 182 | 296 | $91,941 | $25,496 |
| 2021 | 3 | 196 | 320 | $102,506 | $27,385 |
| 2020 | 2 | 95 | 171 | $56,389 | $12,108 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 99 | 209 | $67,074 | $19,371 | 28.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 35 | $11,223 | $3,136 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 30 | $7,028 | $1,877 | 26.7% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2023 | 24 | 25 | $13,425 | $1,200 | 8.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 92 | 187 | $56,686 | $17,773 | 31.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 38 | $11,579 | $3,672 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 31 | $6,916 | $1,890 | 27.3% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 24 | 25 | $13,425 | $1,248 | 9.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 15 | $3,335 | $913.46 | 27.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 85 | 189 | $55,301 | $18,182 | 32.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 43 | 57 | $16,746 | $5,426 | 32.4% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 41 | 45 | $24,165 | $2,176 | 9.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 18 | $3,906 | $934.36 | 23.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 11 | 11 | $2,387 | $667.40 | 28.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 53 | 127 | $37,160 | $9,532 | 25.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 18 | $5,267 | $1,310 | 24.9% |
| 38222 | Bone marrow biopsy and aspiration | Facility | 2020 | 26 | 26 | $13,962 | $1,266 | 9.1% |
About Mary Steinbach, APRN
Mary Steinbach, APRN is a Family healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2012. The National Provider Identifier (NPI) number assigned to this provider is 1881958189.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Steinbach, APRN has received a total of $156,225 in payments from pharmaceutical and medical device companies, with $56,095 received in 2024. These payments were reported across 249 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($89,961).
As a Medicare-enrolled provider, Steinbach has provided services to 650 Medicare beneficiaries, totaling 1,086 services with total Medicare billing of $90,573. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Salt Lake City, UT
- Active Since 07/02/2012
- Last Updated 11/19/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1881958189
Products in Payments
- DARZALEX (Biological) $56,033
- TECVAYLI (Biological) $21,220
- BLENREP (Biological) $17,541
- ELREXFIO (Drug) $17,504
- Pomalyst (Drug) $15,739
- XPOVIO (Drug) $8,999
- ABECMA (Biological) $4,580
- CARVYKTI (Drug) $3,758
- CARVYKTI (Biological) $140.92
- TALVEY (Biological) $96.91
- SARCLISA (Biological) $53.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Salt Lake City
Katrina Bawden, Aprn, APRN
Family — Payments: $312,296
Jared Thorley, Aprn, APRN
Family — Payments: $250,996
Jennalyn Mayeux, D.n.p, D.N.P
Family — Payments: $107,580
Melonie Thompson
Family — Payments: $44,954
Christina Cardon, Fnp, FNP
Family — Payments: $21,070
Jennifer Lloyd, Fnp, FNP
Family — Payments: $11,225